Dec 17, 2012
Announces the successful completion of phase3(b) clinical trials on PMIM, a treatment for isceral leishmaniasis (VL or kala-azar). It then outlines the methods used and gives an overview of the treatment and the disease.
Nov 12, 2012
PATH's Drug Development program has developed a new medication to treat diarrhea. This new drug treats the diarrheal process to shorten its duration.
Jul 23, 2012
Dr. Ponni Subbiah will join OneWorld Health on August 1st, 2012 as its first global program leader.
May 30, 2012
Dr. Geno deHostos, OneWorld Health's Director of Research and Preclinical Development, spoke at NIH about the important role product development partnershops play in creating new treatments for neglected tropical diseases.
Apr 02, 2012
Will be used to develop a new anti-diarrheal drug for use in the developing world
Feb 21, 2012
OWH will move forward with its partners on public health studies to help the government determine the best way to distribute and use the treatment in its public health system throughout the VL-endemic regions.
Dec 21, 2011
A safety and efficacy of an important study for a new treatment for the deadly visceral leishmaniasis (VL, kala-azar or black fever) moves forward.
Nov 29, 2011
The campaign is supported by an educational grant from Sanofi Pasteur in India
Nov 07, 2011
Will Focus on New Treatment Modalities for this Deadly Disease
Nov 04, 2011
OneWorld Health teams up with A-Cube to develop DNA Vaccines